Equity Capital Markets

Company · CIK 1703057

AbCellera Biologics Inc.

Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26

CIK1703057 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inA1
Business addressBritish Columbia, Canada
ListedABCL (Nasdaq)
First annual or quarterly report2021-03-30

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-285367
ShelfEffective
 2025-02-272026-08-133
333-256998
Registered companyEffective
 2021-06-102022-08-113
333-263047
ShelfEffective
 2022-02-252022-02-251
333-250838
IPOFinal prospectus
 2020-11-202020-12-146

Filings

14
FiledFilingRegistrationAccession
2026-08-13424B5Shelf takedown 333-2853670001193125-26-349333
2026-08-11424B5Shelf takedown 333-2853670001193125-26-344944
2025-02-27S-3ASRShelf registered 333-2853670001193125-25-039391
2022-08-11EFFECTDeclared effective 333-2569989999999995-22-002331
2022-02-25S-3ASRShelf registered 333-2630470001140361-22-006833
2021-06-21EFFECTDeclared effective 333-2569989999999995-21-002431
2021-06-10S-1Registration filed 333-2569980001193125-21-187930
2020-12-14424B4Final prospectus 333-2508380001193125-20-316986
2020-12-10EFFECTDeclared effective 333-2508389999999995-20-003483
2020-12-10S-1/AAmendment 333-2508380001193125-20-314458
2020-12-07S-1/AAmendment 333-2508380001193125-20-311091
2020-11-25S-1/AAmendment 333-2508380001193125-20-302988
2020-11-20S-1Registration filed 333-2508380001193125-20-299507
2020-10-05DRSDraft made public 377-036300000950123-20-010081

All filings of this company · CSV